004310.KS
Hyundai Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,680.00
+1.45%Leverage
- Debt / equity
- 0.39x
- Net debt / equity
- 0.33x
- Debt / assets
- 0.22x
- Debt / EBITDA
- 4.36x
- Net debt / EBITDA
- 3.69x
Liquidity & coverage
- Current ratio
- 1.69x
- Quick ratio
- 1.10x
- Cash ratio
- 0.29x
- Interest coverage
- 3.30x
- EBITDA / interest
- 6.22x
- Working capital
- KRW 44.4B
Cash & dividend
- FCF / debt
- -0.01x
- Cash flow / debt
- 0.06x
- Dividend per share
- KRW 30
- Dividend yield
- 0.4%
- Dividend growth 1y
- +0.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of May 1, 2026